
doi: 10.1093/bja/52.1.85
pmid: 6990948
Glycopyrrolate, a quaternary ammonium anticholinergic compound, and atropine were evaluated in combination with neostigmine for antagonism of non-depolarizing neuromuscular block. A total of 641 patients were investigated in a "true-to-life" situation. The patients receiving glycopyrrolate with neostigmine had smaller changes in heart rate than those who received atropine. This was particularly apparent in patients with cardiovascular disease.
Atropine, Male, Clinical Trials as Topic, Pyrrolidines, Time Factors, Neuromuscular Junction, Middle Aged, Glycopyrrolate, Neostigmine, Random Allocation, Double-Blind Method, Heart Rate, Humans, Female, Neuromuscular Blocking Agents
Atropine, Male, Clinical Trials as Topic, Pyrrolidines, Time Factors, Neuromuscular Junction, Middle Aged, Glycopyrrolate, Neostigmine, Random Allocation, Double-Blind Method, Heart Rate, Humans, Female, Neuromuscular Blocking Agents
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 61 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 1% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
